Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
previously undiscovered protein marker shows 56% increase in survival..agree fda will give early approve to axal for this indicator..share price up to tutes lending to short sellers..10 million short shares cause big dilution..but buying them back inverse is true..which side would you rather be on..long or short..shorts have had it all their way only because of willingness to lend to shorts..and skeptical investors on cancer vaccine therapy..
According to press release..clear protein marker has been identified.
stressing over share holder value as an expression of s/p is ridiculous under these technical circumstances..so is bashing doc but he needs to figure a way to get the shorts off our back..otherwise its gonna suck for as long as they own us with borrowed shares..
big short interests have a grip here..and nwbo under the radar now..but not for long..partnerships and financing await..
.adxs is owned by short interests who have kept a 8-10 million short share balance over the last year..as long as that goes on s/p will be determined by those short shares trading daily..not until that ends will the price go up. so wait.
investor sentiment towards small bios doing cancer vaccine work aren't very popular now..but that may all change next few weeks with the nwbo read out of their phase 3 trial results for their dcvax glioblastoma treatment.they are back from the dead..
..this treatment approval will usher in a sea change in investor sentiment towards vaccine therapy..but short interest is strong..however continue high demand for the stock will eventually terminate the choke hold on what appears to be a growing consensus for approval against a background of value-increasing financials..
for the last year adxs has carried a 25%-28% short interest..to date there is no sign short owners are concerned or interested in covering..once the lenders decide to recall the borrowed shares then we will see a scramble..but i doubt it will be dramatic..these intermittent take downs are very managed..without the borrowed shares there was no way to initiate the volume needed for the take down..now those shares have/are finding permanent homes..more share borrowing will be required to lower the price again..there is evidence tutes are buying on these down turns..recent articles on first quarter activity confirms it..
so just relax and enjoy the ride..most of us have been driven around the s/p curve..the share price just goes where it goes..if you figure out one pattern it switches..
adxs should announce a merger with their partnered genome mapping company. takes care of a lot of issues..and wipes out shorts overnight.
investors know new lows are part of the journey up..it always has been..
the financing is value creation..so money and parternships are coming..once news gets out about this..s/p could rapidly icrease as early as tomorrow and definitely next week.. 5xs volumne today..shares are about to become very scarce..but shorts will need to cover..
adxs as soc..replacing chemo and radiation..no company BO..those wanting it want doc gone..anti-doc club has taken over here..but irrelevant..sad wantabes..
500m from amgen and 300m from sellas. adxs is selling franchises not itself..but fbg your adxs fantasies keep leaving out sellas..and the possibility of engineering adjuncts to attack other genetic markers for other treatments.
adxs booked over 900 million in future revenue..timeline for payment is however unknown..so surprise revenue announcement in the cards..
gantor50..really nice summary of last weeks blitz attack..wipe out calls puts and margin plays..reset the o/s ..its happened before as we all know....now what? rinse and repeat..free market LOL..call it bot managed real time asset price manager..the margin calls no doubt hurt a lot of people..criminal?..hey its American capitalism..understand it..use it..
with 20% of the o/s borrowed..and no upward catalysts or market visibility not too surprising this HFT bot is in control..do we bounce around down here for a while..demand for stock is the answer..how many shares will it cost to keep the price so low..i doubt we stay here long and am amazed we got here at all...retail shorts likely covered long ago..this is an institutional take down..
all eyes on adxs.did FINRA notice...this has certainly attracted the streets attention with many analysts puzzeled as to why..10 million short shares is why..the real share harvest will begin as we increase in price..no one sold much down here..and total volume during this short blitz still less than shares needed to cover..so ride up should be fun..all eyes on adxs very very cool..the longer the wait to go up the more it costs..but our short owners do not care..
invest0rs--its called the 21st century cures act.it creates accelerated approval pipeline for orphan drugs for terminal disease. This sell off fed by short selling storm is not uncommon for adxs..neither is a strong recovery..
Iggy no matter..black Monday Coming..sell it all
Pile it on guys..do must go
Blue no matter..share price says it all..sell sell sell black Monday. Coming .ah feel better just thinking of it..
Fbg..you the man..tell us we sell it to Amgen for a few bottles of whiskey..at least we get a good binge ..I'm all done
10 million short shares..25% of company is air. What would you do
.
Raja and on Monday real selling begins
Get rid of this on any temp uptick..dummies..who needs to be millionaire..
Does it matter..sell sell before rush to exit tomorrow..it's the end of the world.
Adxs is dead..no one wants it..shut down let's go home it's all over..ow well
All hope is lost..fines pin heads useless..this is fun and easy.
Sold every thing..somebody help me..lol
All is lost..the sky is falling..fools.
Back to 4.00..ok .sell this pos. I'll buy
I'm doing what retail does ..waiting..all the noise here is just that. Obviously someone wants this in a big way..bury this technology..who knows..
Bmy spinning another fantasy.
lol avxl mc 236m adxs 290m..wtf.market efficacy a joke. .buy buy adxs
wow big share shake..hold on doc..you the man..9 million shares trading that do not exist..adxs is a flea to our short owners..need more proof.this message board continues to.manufacture reality.. we are in the home stretch..desparate for shares..water water everwhere not a drop to drink.
one of the original goals was a trial with merck and her2..was suppose to start back in jan 2015..buthaven't heard much about since..
feels like adxs is about to have an impact and be valued on its ability to engineer genetic markers on cancer cells for the immune system to attack..a keytudra factory..for different genetic variations..thats what the man said..amgen signed on for 500,000,000..there's selene deal..and progress on several other constructs..analysis of cancer genome will facilitate approval across genetic type..axal can treat cervical, head neck,anal, not to mention her2 construct and report on psa construct..adxs has made remarkable progress..being able to manufacture its own products..as genome cancer types begin to be identified adxs will be able to engineer targeted treatment types.towards management and cure for cancer..there's a huge financial impact..as the cancer treatment business is enormous..
without buying and reselling shorts cannot manage price as easily..its costing a little more but adxs is a flee to our short owner/s. if adxs were to merge or become owned by its existing partners..it would be worth it to spend to keep the price down..its the only thig that makes sense.
noticed that doc said eu approval is based on independent gog study ..that study showed success in actively treating hpv cervical which is a different emphasis from existing phase 3..that same study could provide early approval under 21st century cures act..we are an orphan drug filling a space to treat deadly disease where there is NO currently available treatment..
good observation shorts aren't covering..the are accumulating and holding like they have long position..very little covering..odd short behavior..but if you plan to go long eventually and have deep pockets.. what does it matter..adxs is a fly to our current and prospective big pharma customers..